Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-808P represents a pseudogene related to the U6 small nuclear RNA (snRNA) family. The U6 snRNA is a critical component of the spliceosome complex, responsible for the splicing of pre-mRNA in eukaryotic cells[1][3]. In contrast, RNU6-808P is a non-functional relic of a U6 gene and does not produce a functional RNA molecule. Such pseudogenes are abundant in the genome but do not have a known biological role or disease relevance, nor are they considered candidates for therapeutic targeting[1][3]. Only the parent gene U6 snRNA, not its pseudogenes, participates in essential catalytic RNA splicing reactions and is highly evolutionarily conserved[1][3].\n- The parent U6 snRNA gene is essential and involved in splicing[1][3], but RNU6-808P, as a pseudogene, is not functional and is thus not a valid molecular or therapeutic target.\n- Pseudogenes are often annotated in genomics databases for completeness, but they lack protein products and defined biological or pathological roles.\n- The presence of numerous U6 pseudogenes reflects evolutionary redundancy, not functional diversity[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 808, pseudogene (RNU6-808P).